Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating ...
July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as ...
July 9, 2024 — Bracco and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Shine Technologies Partners with Blue Earth Therapeutics for First ...
June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...
Blue Earth Diagnostics Announces Agreement with Siemens Healthineers ...
May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...
Blue Earth Therapeutics Announces Promising Results from Preclinical ...
April 10, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...
Blue Earth Therapeutics Announces Publication of Results from ...
February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...
Philochem and Blue Earth Diagnostics Announce First Three Patients ...
December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...
Additional Results of POSLUMA (Flotufolastat F 18) Performance in ...
October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Blue Earth Diagnostics Highlights Presentations on POSLUMA ...
September 27, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F ...
July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...